Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Sees Significant Decline in Short Interest

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 500 shares, a decrease of 28.6% from the October 31st total of 700 shares. Based on an average trading volume of 12,800 shares, the short-interest ratio is presently 0.0 days.

Relief Therapeutics Trading Up 0.3 %

Relief Therapeutics stock traded up $0.02 during trading hours on Friday, reaching $5.60. 327 shares of the stock were exchanged, compared to its average volume of 2,846. Relief Therapeutics has a twelve month low of $1.10 and a twelve month high of $7.66. The stock has a 50 day moving average of $5.64 and a two-hundred day moving average of $2.94.

About Relief Therapeutics

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.